Have a personal or library account? Click to login
Can Plasma α-Synuclein Help Us to Differentiate Parkinson’s Disease from Essential Tremor? Cover

Can Plasma α-Synuclein Help Us to Differentiate Parkinson’s Disease from Essential Tremor?

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Silvia M. Albillos,  Olimpio Montero,  Sara Calvo,  Berta Solano,  José María Trejo and  Esther Cubo  
Open Access
|May 2021

References

  1. 1Delenclos M, Jones DR, McLean PJ, Uitti RJ. Biomarkers in Parkinson’s disease: Advances and strategies. Parkinsonism Relat Disord. 2016; 22 Suppl 1: S106–110. DOI: 10.1016/j.parkreldis.2015.09.048
    Back to article
  2. 2Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain. 2007; 130: 3297–3307. DOI: 10.1093/brain/awm266
    Back to article
  3. 3Mollenhauer B, Caspell-Garcia CJ, Coffey CS, et al. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology, 2017; 89: 1959–1969. DOI: 10.1212/WNL.0000000000004609
    Back to article
  4. 4Gupta V, Garg RK, Khattri S. Serological Analysis of Alpha-synuclein and NF-kappaB in Parkinson’s Disease Patients. J Clin Diagn Res. 2015; 9: BC01–04. DOI: 10.7860/JCDR/2015/12545.5978
    Back to article
  5. 5Bougea A, Stefanis L, Paraskevas GP, Emmanouilidou E, Vekrelis K, Kapaki E. Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019; 40: 929–938. DOI: 10.1007/s10072-019-03738-1
    Back to article
  6. 6Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189–198. DOI: 10.1016/0022-3956(75)90026-6
    Back to article
  7. 7Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007; 22: 2314–2324. DOI: 10.1002/mds.21844
    Back to article
  8. 8Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55: 181–184. DOI: 10.1136/jnnp.55.3.181
    Back to article
  9. 9Fahn S, Elton R. Members of the UPDRS Development Committee Recent Developments in Parkinson’s Disease, Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987.
    Back to article
  10. 10Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord. 2007; 22: 1901–1911. DOI: 10.1002/mds.21596
    Back to article
  11. 11Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson’s disease-cognitive rating scale: A new cognitive scale specific for Parkinson’s disease. Mov Disord. 2008; 23: 998–1005. DOI: 10.1002/mds.22007
    Back to article
  12. 12Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. Neurology, 2000; 54: S7.
    Back to article
  13. 13Tape TG. Interpreting diagnostic tests. University of Nebraska Medical Center, 2008. (Accessed September 10, 2020, at http://gim.unmc.edu/dxtests/Default.htm).
    Back to article
  14. 14Louis ED, Ottman R. Is there a one-way street from essential tremor to Parkinson’s disease? Possible biological ramifications. European journal of neurology. 2013; 20: 1440–1444. DOI: 10.1111/ene.12256
    Back to article
  15. 15Minen MT, Louis ED. Emergence of Parkinson’s disease in essential tremor: A study of the clinical correlates in 53 patients. Mov Disord. 2008; 23: 1602–1605. DOI: 10.1002/mds.22161
    Back to article
  16. 16Tarakad A, Jankovic J. Essential Tremor and Parkinson’s Disease: Exploring the Relationship. Tremor and other hyperkinetic movements (New York, NY). 2018; 8: 589. DOI: 10.5334/tohm.441
    Back to article
  17. 17Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism Relat Disord. 2007; 13: 67–76. DOI: 10.1016/j.parkreldis.2006.05.033
    Back to article
  18. 18Espay AJ, Lang AE, Erro R, et al. Essential pitfalls in “essential” tremor. Mov Disord. 2017; 32: 325–331. DOI: 10.1002/mds.26919
    Back to article
  19. 19Budisic M, Trkanjec Z, Bosnjak J, Lovrencic-Huzjan A, Vukovic V, Demarin V. Distinguishing Parkinson’s disease and essential tremor with transcranial sonography. Acta Neurol Scand. 2009; 119: 17–21. DOI: 10.1111/j.1600-0404.2008.01056.x
    Back to article
  20. 20Yilmaz R, Berg D. Transcranial B-Mode Sonography in Movement Disorders. Int Rev Neurobiol. 2018; 143: 179–212. DOI: 10.1016/bs.irn.2018.10.008
    Back to article
  21. 21Gorostidi A, Bergareche A, Ruiz-Martinez J, et al. Alphalpha-synuclein levels in blood plasma from LRRK2 mutation carriers. PLoS One. 2012; 7: e52312. DOI: 10.1371/journal.pone.0052312
    Back to article
  22. 22Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K. The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy. Journal of neural transmission (Vienna, Austria : 1996). 2006; 113: 1435–1439. DOI: 10.1007/s00702-005-0427-9
    Back to article
  23. 23Yang F, Li WJ, Huang XS. Alpha-synuclein levels in patients with multiple system atrophy: A meta-analysis. Int J Neurosci. 2018; 128: 477–486. DOI: 10.1080/00207454.2017.1394851
    Back to article
  24. 24Barbour R, Kling K, Anderson JP, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008; 5: 55–59. DOI: 10.1159/000112832
    Back to article
  25. 25Shi M, Zabetian CP, Hancock AM, et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease. Neurosci Lett. 2010; 480: 78–82. DOI: 10.1016/j.neulet.2010.06.009
    Back to article
  26. 26Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013; 27: 647–661. DOI: 10.1016/j.beem.2013.05.011
    Back to article
  27. 27Bidinosti M, Shimshek DR, Mollenhauer B, et al. Novel one-step immunoassays to quantify alpha-synuclein: applications for biomarker development and high-throughput screening. J Biol Chem. 2012; 287: 33691–33705. DOI: 10.1074/jbc.M112.379792
    Back to article
DOI: https://doi.org/10.5334/tohm.600 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jan 9, 2021
Accepted on: May 10, 2021
Published on: May 28, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Parkinson’s disease,
Essential tremor,
alpha-synuclein,
plasma biomarker,
diagnosis

© 2021 Silvia M. Albillos, Olimpio Montero, Sara Calvo, Berta Solano, José María Trejo, Esther Cubo, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article